n Cardiovascular Journal of South Africa - Pravastatin benefits elderly patients: results of PROSPER study : drug trends in cardiology




Extracted from text ... Pravastatin benefits elderly patients: results of PROSPER study The first study to specifically examine the effects of statin treatment in the elderly has demonstrated that pravastatin (Prava) has significant benefits in this group of patients. After only three years of treatment with pravastatin, there was a significant reduction in the combined primary endpoint of coronary heart disease or non-fatal myocardial infarction or fatal or non-fatal stroke and a 24% reduction in death from coronary heart disease. Previous large-scale trials including a combined patient base of over 25 000 patients have shown that pravastatin significantly reduces cardio- and cerebrovascular morbidity and ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error